Suspected infection in children with cancer

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue SUPL. S1, 2002, Pages 63-67

  Shaw, Peter J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUSULFAN; CEFALOTIN; CEPHALOSPORIN DERIVATIVE; CYTARABINE; GENTAMICIN; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; ITRACONAZOLE; LIPID EMULSION; TICARCILLIN; VANCOMYCIN;

ADULT; ANTIFUNGAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CANCER THERAPY; CANDIDA ALBICANS; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DATA BASE; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MYCOSIS; NEPHROTOXICITY; NEUTROPHIL; PROSPECTIVE STUDY; RANDOMIZATION; SCEDOSPORIUM; SEPSIS; VIRUS INFECTION;

EID: 0036178413     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/49.suppl_1.63     Document Type: Article

References (5)

1. Hematopoietic growth factors - Not whether, but when and where
2. Scedosporium infection in immunocompromised patients: Successful use of liposomal amphotericin B and itraconazole
3. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis
4. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients
5. Amphotericin B in children with malignant disease: A comparison of the toxicity and pharmacokinetics of amphotericin B administered in dextrose or lipid emulsions